A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses of JNJ-53718678 in Children ?28 Days

Project: Research project

Project Details

StatusActive
Effective start/end date2/22/19 → 8/31/50

Funding

  • Janssen Research & Development, LLC